In the latest market close, Badger Meter (BMI) reached $220, with a +1.44% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 1.1% for the day. On the other hand, the Dow registered a gain of 0.91%, and the technology-centric Nasdaq increased by 1.35%.The the stock of manufacturer of products that measure gas and water flow has fallen by 1.53% in the past month, lagging the Computer and Technology sector's gain of 5.09% and the S&P 500's gain of 0.22%.Market pa ...

Core Viewpoint - Badger Meter (BMI) has shown strong stock performance, with a 5% increase over the past month and a 49.4% gain since the beginning of the year, outperforming both the Zacks Computer and Technology sector and the Zacks Instruments - Control industry [1][2]. Financial Performance - Badger Meter reported an EPS of $1.08 in its latest earnings report, exceeding the consensus estimate of $1.02, although it missed the revenue estimate by 0.28% [2]. - For the current fiscal year, the company is projected to achieve earnings of $4.19 per share on revenues of $820.32 million, reflecting a 33.44% increase in EPS and a 16.59% increase in revenues [3]. - The next fiscal year forecasts earnings of $4.74 per share on revenues of $887.29 million, indicating year-over-year changes of 13.22% in EPS and 8.16% in revenues [3]. Valuation Metrics - Badger Meter's current valuation metrics indicate a premium, trading at 55.1X current fiscal year EPS estimates compared to the peer industry average of 25.2X, and at 56.1X on a trailing cash flow basis versus an average of 21.8X for peers [7]. - The stock has a PEG ratio of 2.9, which does not place it among the top value stocks [7]. Zacks Rank and Style Scores - Badger Meter holds a Zacks Rank of 2 (Buy), supported by favorable earnings estimate revisions from analysts [8]. - The stock has a Value Score of C, a Growth Score of B, and a Momentum Score of C, resulting in a combined VGM Score of B [6][9].

In the latest trading session, Badger Meter (BMI) closed at $220.56, marking a +1.72% move from the previous day. This change outpaced the S&P 500's 0.25% gain on the day. At the same time, the Dow lost 0.29%, and the tech-heavy Nasdaq gained 0.97%.The manufacturer of products that measure gas and water flow's shares have seen an increase of 7.35% over the last month, surpassing the Computer and Technology sector's gain of 0.06% and the S&P 500's gain of 3.51%.Analysts and investors alike will be keeping a ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zack ...

Core Viewpoint - Badger Meter (BMI) has experienced a significant stock price increase of 39.8% year to date, outperforming both the S&P 500 and its sub-industry growth rates, raising questions about the sustainability of this rally [1] Group 1: Demand and Revenue Growth - There is a robust demand for digital smart water solutions, driven by challenges in the water industry, leading to increased adoption of BMI's smart water solutions, including mechanical and E-Series Ultrasonic meters, ORION Cellular endpoints, and BEACON Software-as-a-Service (SaaS) [4] - SaaS revenues grew approximately 35% in the third quarter, reflecting a rising customer reliance on insights from BEACON digital solutions, supported by favorable macroeconomic factors and a strong opportunity funnel [5] - Utility water sales increased by 14% in the third quarter, attributed to the adoption of the BlueEdge framework, which offers customizable solutions for the entire water cycle [6] Group 2: Profitability and Financial Health - BMI's gross profit reached $83.9 million in the third quarter, marking a 15.3% year-over-year increase, with a gross margin of 40.2%, up 110 basis points from the previous year [8] - The company maintains a debt-free balance sheet with $259 million in cash and cash equivalents as of September 30, 2024, and reported a record quarterly free cash flow of $42 million, indicating strong earnings and working capital management [10] - BMI announced a 26% increase in its quarterly dividend to 34 cents per share, marking 32 consecutive years of dividend increases, with a payout ratio of 0.34 [11] Group 3: Challenges and Market Outlook - Sales of flow instrumentation products are facing challenges due to declines in certain de-emphasized applications globally, and hurricane recovery activities may delay utility projects in the Southeast U.S., introducing uncertainty [12] - The company anticipates fewer customer operating days in the fourth quarter due to the holiday season, which may lead to reduced sales growth, projecting high single-digit sales growth rates moving forward [13] - Rising operating expenses, particularly in selling, engineering, and administration, increased to $43.3 million in the third quarter, which could pressure margins if not offset by revenue growth [14] Group 4: Valuation Concerns - BMI is currently trading at a high valuation, with a forward 12-month price-to-earnings ratio of 46.59, significantly above the industry average of 19.72, raising concerns about its investment attractiveness [15]

Core Insights - Rhythm Pharmaceuticals presented new real-world data indicating significant reductions in body mass index (BMI) and improvements in hunger scores among adult patients with acquired hypothalamic obesity treated with setmelanotide [1][2][3] Group 1: Real-World Data Analysis - In a study of eight adult patients, mean BMI decreased by 5.6% after one month, 12.8% after three months, and 21.3% after six months of setmelanotide treatment [2] - All patients experienced a weight reduction of 5% or more after three months, and all showed reductions in multiple hunger score categories [2] - No new safety signals were reported during the treatment period [2] Group 2: Phase 2 and Phase 3 Trial Results - Phase 2 trial data showed a mean BMI reduction of 12.4% in patients with rare MC4R pathway diseases after 40 weeks of continuous setmelanotide therapy [1][5] - In the Phase 3 VENTURE trial, pediatric patients aged 2 to <6 years achieved a mean BMI reduction of 23.8% after 18 months of treatment [1][7] - The Phase 2 trial demonstrated a greater reduction in fat mass (29.6%) compared to lean muscle mass (7.7%) after 12 months of treatment [4] Group 3: Genetic Testing Insights - Analysis of over 43,000 genetic samples revealed a 7.39% positivity rate for likely pathogenic variants associated with early-onset obesity [9][10] - Family history of genetic disease was significantly linked to positive test results, and early-onset hyperphagia was more common in individuals with positive genetic findings [10] Group 4: Company Overview - Rhythm Pharmaceuticals focuses on developing treatments for rare neuroendocrine diseases, with setmelanotide being its lead asset approved for chronic weight management in specific obesity cases [12][13] - The company is advancing a broad clinical development program for setmelanotide and other investigational MC4R agonists [12]

Company Overview - Badger Meter, Inc. (NYSE: BMI) has been innovating in water technology for over a century, providing industry-leading water solutions that include flow measurement, quality, and other system parameters [1]. Industry Insights - The company operates as a global provider in the water technology sector, focusing on solutions that enhance water management and measurement [1].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-06706 BADGER METER, INC. (Exact name of registrant as specified in its charter) 39-0143280 (I.R.S. Employer Identification ...

Badger Meter, Inc (BMI) reported earnings per share (EPS) of $1.08 for third-quarter 2024, beating the Zacks Consensus Estimate by 5.9%. Also, the bottom line compared favorably with the year-ago quarter's EPS of 88 cents. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar Quarterly net sales were $208.4 million, up 12% from $186.2 million in the year-ago quarter. The uptick resulted from continued strong yet normalizing demand for its tailorable water management solutions. However, th ...

Financial Data and Key Metrics Changes - The company reported a 12% year-over-year sales growth in Q3 2024, following a 26% increase in the prior year comparable quarter [4][5] - Operating margins reached a record high of 19.5%, with gross margins improving to 40.2%, up from 39.1% in the prior year [6][7] - Consolidated EPS improved by 23% to $1.08 from $0.88 in the prior year [9] - Free cash flow reached a record $42 million, a 48% increase from $28 million in the previous year [9] Business Line Data and Key Metrics Changes - Total utility water product line sales increased by 14% year-over-year, driven by strong demand for the BlueEdge suite of utility smart water solutions [5] - Software as a Service (SaaS) revenues grew approximately 35% in the quarter, reflecting increased customer reliance on the BEACON digital solution [5][6] - Sales for the flow instrumentation product line remained flat, with solid order trends in focused water-related applications [6] Market Data and Key Metrics Changes - The company anticipates fewer customer operating days in Q4 due to the U.S. holiday season, which may impact sales [6][13] - Hurricane-related recovery activities could delay certain utility projects in the Southeastern U.S., although the impact is still uncertain [6][13] Company Strategy and Development Direction - The company continues to focus on high single-digit sales growth rates over the strategic cycle, with a strong opportunity funnel and bid pipeline [13] - The BlueEdge suite is designed to provide tailored solutions for customers, enhancing their ability to manage water efficiently [10][11] - The company remains committed to capital allocation priorities, including R&D leadership, dividend increases, and strategic M&A opportunities [14][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver strong results despite potential unevenness in quarterly performance [16][20] - The macro drivers for technology adoption in the water industry are becoming more pronounced, particularly due to extreme weather events and aging infrastructure [12][13] - Management does not expect down years in sales, citing strong historical performance even during challenging times [19][20] Other Important Information - The company is transitioning its investor relations leadership, with Karen Bauer set to retire in spring 2025 [2] - The company has maintained a healthy balance sheet and cash flow generation profile, allowing for continued investment in growth [14] Q&A Session Summary Question: Outlook for 2025 sales growth - Management indicated that while growth may moderate, they do not expect a down year, citing strong macro drivers in the industry [16][19] Question: Drivers of margin improvement - Management confirmed that margin improvement was driven by unit volume increases, pricing, and product mix [18] Question: Impact of hurricanes on business - Management acknowledged potential delays in projects due to hurricanes but emphasized that they do not expect cancellations [20][22] Question: Backlog normalization - Management stated that the backlog remains positive, with no significant changes noted in the current quarter [24] Question: SaaS revenue growth drivers - The majority of SaaS revenue growth is attributed to a 100% attachment rate to hardware sales, with additional contributions from new services [25][26] Question: International market opportunities - Management highlighted growth in international markets, particularly through acquisitions that have established customer relationships [38][39]